St. Jude doctors were able to transfuse a father's natural immune system killer cells
to save the life of his 3-month-old infant daughter who was struggling to survive acute lymphoblastic leukemia.
According to St. Jude researchers, this procedure has been successful in older children, but not so much for infants.
The St. Jude researchers reported that, after 16 months, the young girl is still in remission.“This is in marked contrast to the invariably fatal outcome we see in infants with ALL who receive a hematopoietic cell transplant after they relapse following an initial treatment,” states Wing Leung, MD, PhD, Hematology-Oncology.
St. Jude Children's Research Hospital pediatric treatment and research facility has a worldwide reputation of being able to treat the most challenging cancer cases. All pediatric patients accepted are treated without regard to the family's ability to pay.
